SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla informs about board meeting

19 Apr 2022 Evaluate

Cipla has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th May 2022 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31st March 2022 and recommendation of dividend, if any. In compliance with the provision of the Company's Code of Conduct for Prevention of Insider Trading, the ‘Trading Window' for dealing in the securities of the Company has been closed from Friday, 1st April, 2022 up to Thursday, 12th May, 2022.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1232.90 4.00 (0.33%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×